These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32061309)

  • 1. The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy.
    Ramírez-Labrada AG; Isla D; Artal A; Arias M; Rezusta A; Pardo J; Gálvez EM
    Trends Cancer; 2020 Feb; 6(2):86-97. PubMed ID: 32061309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Role of Gut Microbiota in Lung Carcinogenesis and Cancer Immunotherapy].
    Shoji F
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):597-602. PubMed ID: 39009513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?
    Wieczorska K; Stolarek M; Stec R
    Clin Colorectal Cancer; 2020 Mar; 19(1):5-12. PubMed ID: 31678050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiome: A Supportive or a Leading Actor in Lung Cancer?
    Martins D; Mendes F; Schmitt F
    Pathobiology; 2021; 88(2):198-207. PubMed ID: 33352574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
    Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
    Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on the role of gut microbiota in immune checkpoint blockade therapy for cancer.
    Kim E; Ahn H; Park H
    Mamm Genome; 2021 Aug; 32(4):223-231. PubMed ID: 33783613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review.
    Cruellas M; Yubero A; Zapata M; Galvez EM; Gascón M; Isla D; Lastra R; Martínez-Lostao L; Ocariz M; Pardo J; Ramírez A; Sesma A; Torres-Ramón I; Paño JR
    Infect Immun; 2021 Aug; 89(9):e0066520. PubMed ID: 33526567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Host Microbiota Contributes to Early Protection Against Lung Colonization by
    Dumas A; Corral D; Colom A; Levillain F; Peixoto A; Hudrisier D; Poquet Y; Neyrolles O
    Front Immunol; 2018; 9():2656. PubMed ID: 30487801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-microbiota interplay in mediating immune disorders.
    Felix KM; Tahsin S; Wu HJ
    Ann N Y Acad Sci; 2018 Apr; 1417(1):57-70. PubMed ID: 28984367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbes and Cancer.
    Dzutsev A; Badger JH; Perez-Chanona E; Roy S; Salcedo R; Smith CK; Trinchieri G
    Annu Rev Immunol; 2017 Apr; 35():199-228. PubMed ID: 28142322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-Microbiome Interaction in Lung Cancer.
    Dong Q; Chen ES; Zhao C; Jin C
    Front Immunol; 2021; 12():679829. PubMed ID: 34108973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of immunomodulatory drugs on the gut microbiota.
    Cohen I; Ruff WE; Longbrake EE
    Transl Res; 2021 Jul; 233():144-161. PubMed ID: 33515779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer.
    Wu Z; Man S; Sun R; Li Z; Wu Y; Zuo D
    Int Immunopharmacol; 2020 Aug; 85():106613. PubMed ID: 32450531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes.
    Bartolini I; Risaliti M; Ringressi MN; Melli F; Nannini G; Amedei A; Muiesan P; Taddei A
    World J Gastroenterol; 2020 May; 26(20):2498-2513. PubMed ID: 32523307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.
    Serino M; Blasco-Baque V; Nicolas S; Burcelin R
    Curr Cardiol Rep; 2014 Nov; 16(11):540. PubMed ID: 25303894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium and Enterobacteriaceae: important players for CRC?
    Allen-Vercoe E; Jobin C
    Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lung and gut microbiota on lung cancer pathogenesis.
    Zhao Y; Liu Y; Li S; Peng Z; Liu X; Chen J; Zheng X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2177-2186. PubMed ID: 34018055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.